Cairo - Mubasher: Minapharm Pharmaceuticals on Wednesday reported a 59% year-on-year increase in standalone profits for the first nine months of 2018.
Net profit stood at EGP 42.6 million in the January-September period, versus EGP 26.8 million in the year-ago period, the company said in a filing to the Egyptian Exchange (EGX).
Sales grew to EGP 1.07 billion at the end of September from EGP 921.37 million in the corresponding nine-month period of 2017.
Minapharm previously posted a net profit of EGP 104.4 million in the first half of this year, versus EGP 100.14 million in H1-17.
